Time trends in preemptive kidney transplantation in Europe: an ERA registry study
Anneke Kramer, Rianne Boenink, Cynthia G Mercado Vergara, Samira Bell, Julia Kerschbaum, Olga Lucía Rodriguez Arévalo, Auxiliadora Mazuecos, Aiko P. J. de Vries, Anna Varberg Reisæter, Esther Wong, Torbjörn Lundgren, María O. Valentín, Flor Angel Ordoñez Alvarez, Edoardo Melilli, Patrik Finne, Mårten Segelmark, Cécile Couchoud, Søren Schwartz Sørensen, Pietro Manuel Ferraro, Miha Arnol, Mustafa Arıcı, Alberto Ortíz, Kitty J. Jager, Daniel Abramowicz, Vianda S Stel, Rachel Hellemans
Abstract
BACKGROUND: Preemptive kidney transplantation (PEKT) has better outcomes when compared with transplantation after dialysis. We aimed to examine trends in PEKT between 2000 and 2019 in Europe and to provide an overview of associated policies, barriers and initiatives. METHODS: Adult patients from 12 European countries who received a preemptive kidney transplant were included. The representatives of the registries providing these data were questioned on the policies, barriers and initiatives around PEKT. RESULTS: Between 2000 and 2019, 20 251 adults underwent PEKT [11 169 from living donors (LDs), 8937 from deceased donors (DDs)]. The proportion of first kidney transplantations that were preemptive more than doubled from 7% in 2000 to 18% in 2019, reflecting a similar relative increase for LD kidney recipients (from 21% to 43%) and DD kidney recipients (from 4% to 11%). Large international differences were found. The increase in PEKT was observed across all age, sex and primary renal disease groups. Countries had similar criteria for preemptive waitlisting. Barriers mentioned included donor shortage, late referral to the transplant center and long donoror recipient work-up. Suggested initiatives included raising awareness on the possibility of PEKT, earlier start and shorter work-up time for recipient and LD. CONCLUSIONS: Over the last two decades the proportion of patients receiving a first kidney transplant preemptively has more than doubled, reflecting a similar relative increase for living and DD kidney recipients.